CNR Institutional Research Information System

DE FRANCISCIS, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.480
NA - Nord America 1.199
EU - Europa 434
SA - Sud America 377
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 45
OC - Oceania 1
Totale 3.621
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.135
SG - Singapore 650
CN - Cina 300
BR - Brasile 298
IT - Italia 171
VN - Vietnam 170
HK - Hong Kong 154
FR - Francia 88
KR - Corea 57
NL - Olanda 56
JP - Giappone 30
CA - Canada 28
AR - Argentina 26
GB - Regno Unito 24
BD - Bangladesh 23
DE - Germania 23
IN - India 23
MX - Messico 20
EC - Ecuador 17
CO - Colombia 14
FI - Finlandia 13
ZA - Sudafrica 13
IL - Israele 10
ID - Indonesia 8
MA - Marocco 8
TR - Turchia 8
VE - Venezuela 8
IQ - Iraq 7
AT - Austria 6
ES - Italia 6
PY - Paraguay 6
UZ - Uzbekistan 6
EG - Egitto 5
HU - Ungheria 5
PH - Filippine 5
RU - Federazione Russa 5
AL - Albania 4
GR - Grecia 4
IE - Irlanda 4
JM - Giamaica 4
NI - Nicaragua 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
KE - Kenya 3
MY - Malesia 3
PL - Polonia 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UA - Ucraina 3
UY - Uruguay 3
BB - Barbados 2
BO - Bolivia 2
DZ - Algeria 2
LT - Lituania 2
NP - Nepal 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SC - Seychelles 2
SE - Svezia 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CD - Congo 1
CG - Congo 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LY - Libia 1
ME - Montenegro 1
NO - Norvegia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZM - Zambia 1
Totale 3.537
Salva come PNG Salva come JPEG
Città #
Singapore 406
Santa Clara 254
Hong Kong 152
San Jose 122
Hefei 107
Ashburn 74
Lauterbourg 73
Beijing 70
Ho Chi Minh City 65
Council Bluffs 60
Seoul 56
Los Angeles 49
Hanoi 36
São Paulo 36
Milan 25
Naples 25
New York 22
Princeton 22
Tokyo 20
Atlanta 14
Dallas 14
Marigliano 13
Abbeville 11
Da Nang 11
Frankfurt am Main 11
Curitiba 10
Montreal 10
Buffalo 9
Rio de Janeiro 9
Bogotá 8
Helsinki 8
Philadelphia 8
Brasília 7
Figino 7
Houston 7
Minamishinagawa 7
Rome 7
Bengaluru 6
Chicago 6
Dhaka 6
Guayaquil 6
Johannesburg 6
London 6
Orem 6
Palermo 6
Quito 6
Tashkent 6
The Bronx 6
Ascoli Piceno 5
Hải Dương 5
Jacksonville 5
Miami 5
Phoenix 5
Turin 5
Amsterdam 4
Baghdad 4
Belo Horizonte 4
Brooklyn 4
Budapest 4
Casablanca 4
Casandrino 4
Düsseldorf 4
Genoa 4
Giugliano in Campania 4
Guarulhos 4
Kingston 4
Lappeenranta 4
Louisville 4
Managua 4
Medellín 4
New London 4
Orlando 4
Toronto 4
Asunción 3
Baltimore 3
Biên Hòa 3
Cairo 3
Campinas 3
Campos dos Goytacazes 3
Cape Town 3
Caruaru 3
Chennai 3
Cincinnati 3
Denver 3
Dublin 3
Harrisburg 3
Manaus 3
Milwaukee 3
Nairobi 3
Phủ Lý 3
Plano 3
Porto Alegre 3
Queens 3
Rosario 3
Salvador 3
San Antonio 3
San Bernardino 3
Sorocaba 3
São Gonçalo 3
Vũng Tàu 3
Totale 2.098
Salva come PNG Salva come JPEG
Nome #
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 105
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation 95
Selection of a nuclease‐resistant rna aptamer targeting cd19 81
Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor 80
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 76
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR beta Aptamer 69
Diagnostic and Therapeutic Aptamers A Promising Pathway to Improved Cardiovascular Disease Management 69
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 67
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells 67
Aptamer-based RNA-bio-drugs for the combined therapy of GBM 65
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 61
Affinity immobilization of aptamers on graphene oxide for biosensor applications 60
A regulatory mechanism involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the control of cell proliferation. 59
A Theranostic "SMART" Aptamer for Targeted Therapy of Prostate Cancer. 58
Identification of an interfering ligand aptamer for EphB2/3 receptors 56
STAT3 targeting by an aptamer-based conjugate for glioblastoma multiforme therapy 56
Targeting breast cancer exosomes with nucleic aptamers: Innovative tools for early diagnosis and therapy 55
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 54
Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3 54
GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. 53
Nucleic acid aptamers targeting epigenetic regulators: An innovative therapeutic option 53
Aptamer chimeras for therapeutic delivery: The challenging perspectives 53
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death 53
Engineering Aptamers for Biomedical Applications: Part II 50
RET/PTC activation in human thyroid carcinomas 50
The isolectin IB4 binds RET receptor tyrosine kinase in microglia. 49
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma 49
Nucleic acids delivering nucleic acids 48
Signaling through Ras Is Essential for ret Oncogene-induced Cell Differentiation in PC12 Cells 47
Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates 46
A trans-disciplinary approach to cancer research 43
Distribution and bioactivity of the Ret-specific D4 aptamer in three-dimensional collagen gel cultures. 41
Aptamers in Bordeaux, 24-25 June 2016 41
The recent blooming of therapeutic aptamers 41
Challenging cancer targets for aptamer delivery. 39
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models 39
Targeting Insulin Receptor with a Novel Internalizing Aptamer. 39
Use of yeast artificial chromosomes to study the genomic organization of human dbl proto-oncogene. 38
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 38
Abrogation of Nerve Growth Factor-induced Terminal Differentiation by ret Oncogene Involves Perturbation of Nuclear Translocation of ERK 38
Aptamer-miRNA conjugates for cancer cell-targeted delivery 38
Noncoding RNAs in Cancer Medicine. 37
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis 37
A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells 37
Recent advance in biosensors for microRNAs detection in cancer 37
Coupling aptamers to short interfering RNAs as therapeutics 36
Nucleic acid aptamers for in vivo molecular imaging 36
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR? Aptamer. 36
Expression of GFRalpha1 receptor splicing variants with different biochemical properties is modulated during kidney development . 36
SERS-active metal-dielectric nanostructures integrated in microfluidic devices for label-free quantitative detection of miRNA 35
cleic acids in human glioma treatment: innovative approaches and recent results 34
Thyrotropin stimulates transcription from the ferritin heavy chain promoter 34
Cell-specific aptamers for targeted therapies. 34
Aptamer-mediated targeted delivery of therapeutics: An update 33
A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation. 33
Aptamers are an innovative and promising tool for phytoplankton taxonomy and biodiversity research 33
Differential SELEX in human glioma cell lines. 33
New insight into clinical development of nucleic acid aptamers. 33
Smooth muscle cell-targeted RNA aptamer inhibits neointimal formation 33
TSH regulation of ferritin H chain messenger RNA levels in the rat thyroids 33
In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing 33
A Trojan horse for human immunodeficiency virus 32
Shp2 in PC12 cells: NGF versus EGF 32
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL 32
Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells 31
Direct interactions among the tyrosine kinase receptor Ret, the GDNF and the GFR±1 molecules. 31
Targeting cancer cells with nucleic acid aptamers 31
Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKs): Evidence for a divergence of the ERKs and JNKs pathways induced by Ret 30
Developing aptamers by cell-based SELEX 30
5'-End ret splicing: absence of variants in normal tissues and intron retention in pheochromocytomas. 30
Arresting the colonial destiny of metastatic seeds with DNA aptamers. 29
An Autocrine Loop Involving Ret and Glial Cell-Derived Neurotrophic Factor Mediates Retinoic Acid-Induced Neuroblastoma Cell Differentiation 29
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells 29
ANALYSIS AND SEQUENCING OF THE GENOMIC DNA REGION SPANNING THE HUMAN DBL PROTOONCOGENE 29
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells 29
Human dbl proto-oncogene in 85 kb of Xq26, and determination of the transcription initiation site. 28
Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase 28
The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination 27
Aptamer-Based Technologies as New Tools for Proteomics in Diagnosis and Therapy Frontiers in Drug Design & Discovery 27
Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors 26
Human dbl proto-oncogene in 85 kb of Xq26, and determination of the transcription initiation site 26
Ligand stimulation of a RET chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B 25
Changes in cellular gene expression in rat thyroid epithelial cells transformed by the Kirsten Murine Sarcoma Virus 24
Nucleic Acid-Based Aptamers As Promising Therapeutics In Neoplastic Diseases 20
Totale 3.621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.899
article - articoli 11.945
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 611
Totale 25.455
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202432 0 0 0 0 0 0 0 0 1 0 20 11
2024/20251.148 8 4 95 40 213 48 51 51 39 73 266 260
2025/20261.812 75 170 213 317 291 86 257 102 79 119 64 39
2026/2027629 140 101 242 146 0 0 0 0 0 0 0 0
Totale 3.621